Finally — Flexible Robotic Manufacturing for Cell and Gene Therapies
Streamline Bio offers an autonomous, cost-effective, AI-driven precision robotic platform for end-to-end cell and gene therapy (CGT) production. Our plug-and-play technology is easy to use and seamlessly integrates into your current manufacturing. Advanced automation. No rebuild required.
Schedule a Discovery Call
An AI-driven precision robotics company transforming how cell and gene therapies are manufactured.
No custom enclosures. No facility redesign. Streamline Bio seamlessly integrates with your existing infrastructure—plug-and-play with your devices, protocols, and compliance systems.
Automation, without the rebuild.
AI-driven Precision Robotics Built for Biomanufacturing
Autonomous, AI-driven systems engineered for the complexities of CGT production—delivering repeatable precision, reduced manual touchpoints, and seamless, end-to-end automation.
Designed to Grow with You
Our modular, plug-and-play architecture scales alongside your pipeline—adapting to new therapies and workflows without the need to overhaul your existing infrastructure.
Process Flexibility at Every Stage
Our modular plug-and-play platform is designed to be process agnostic, device-agnostic, and footprint agnostic; enabling it to seamlessly integrate into your existing infrastructure with minimal costs and no workflow restrictions.
Built on Early-Stage Partnership
We believe in growing together. In these early stages, we collaborate closely with CGT developers—offering flexible engagement models and deep technical support to co-create scalable solutions. Our goal is to be more than a vendor—we're your long-term partner in bringing transformative therapies to patients.
Ready for a Change?
Built to simplify, standardize, and scale.
By mimicking how operators direct existing devices (via touch), we can largely avoid cumbersome and costly 21CFR11 compliance regulations.
Precision robotics decreases run-to-run variation and training burdens; enabling standardization and high-fidelity manufacturing.
From IND to clinical trial to commercial scale — Streamline Bio evolves with your facility, SOPs, and devices — no rebuild required.
Engineered for autologous and allogeneic workflows, handling soft materials, delicate tubing, and patient-specific variability with minimal operator intervention.
Request a demo or partner with us. We'll help automate your cell and gene therapy operations.
Schedule a Discovery Callinfo@streamlinebio.ai · Cambridge, MA